Company page

Adimmune Corporation

Adimmune Corporation, traded under the ticker 4142, is a public company based in Taiwan with a market capitalization of approximately 235.8 million USD. The company specializes in the development and production of vaccines and related products. Adimmune is committed to enhancing public health through innovative solutions in the biopharmaceutical sector.